Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

NULL
   
  • Closing Price Chg:
    -30.00p
  • 52 Week High: NULL
  • 52 Week Low: 1,424.00p
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 0
  • RiskGrade: 128

Key dates

Dividend  
Latest XD Date (Interim) 06-Mar-2025
Latest Pay Date (Interim) 04-Apr-2025
   
Meetings  
AGM 20-Nov-2024
EGM n/a
GMs n/a
   
Announcements  
Trading announcement 15-Jul-2025
IMSs 15-May-2014
Drilling Report n/a
   
Results  
Final results 04-Sep-2025
Interim results 27-Feb-2025
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 14-Oct-2024
   
Year End 30-Jun-2026

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change -30.00p
% Change 0.00 %
52 Week High NULL
52 Week Low 1,424.00p
Volume 0
Shares Issued 66.04m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.41% below the market average92.41% below the market average92.41% below the market average92.41% below the market average92.41% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average
91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average91.11% above the sector average
Income
98.32% below the market average98.32% below the market average98.32% below the market average98.32% below the market average98.32% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.96% below the market average91.96% below the market average91.96% below the market average91.96% below the market average91.96% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Genus Key Personnel

CEO Jorgen Kokke

Top of Page